GO:0035025 positive regulation of Rho protein signal transduction: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035025 describes any process that activates or increases the frequency, rate or extent of Rho protein signal transduction, a central biological_process controlling cytoskeletal dynamics, cell polarity and migration.
• Rho GTPases such as RHOA, RAC1 and CDC42 cycle between GTP-bound active and GDP-bound inactive states; positive regulation shifts this balance toward the active state at the membrane.
• Upstream activators include GEFs, adhesion receptors, growth factor receptors and WNT/FZD complexes that locally concentrate active Rho GTPases.
• Dysregulated positive regulation of Rho signaling drives tumour invasion, amoeboid migration, immune suppression and organ dysfunction in sepsis.
• Key experimental models include CRISPR knockout, point-mutation and knock-in cell lines combined with live imaging, GTPase pull-downs and transcriptomics.
• EDITGENE provides knockout, point-mutation, knock-in, overexpression cell models and CRISPR library screening to dissect this pathway at scale.
Description
GO:0035025, positive regulation of Rho protein signal transduction, is a Gene Ontology biological_process term that captures any process which activates or increases the frequency, rate or extent of Rho protein signal transduction. Rho GTPases are molecular switches that relay extracellular and adhesion-derived cues to the actin cytoskeleton, and their positive regulation is essential for cell polarity, migration, cytokinesis and tissue morphogenesis. Because this term is defined by its regulatory output rather than by a single molecular activity, it integrates signals from GEFs, receptors, adhesion complexes and mechanical inputs. Researchers study GO:0035025 because its dysregulation is a recurring theme in human disease. In cancer, enhanced positive regulation of Rho signaling supports tumour-initiating abilities, amoeboid invasion and metastasis. In immune and inflammatory settings, Rho-GTPase-dependent programs modulate T-cell behaviour and macrophage recruitment. In sepsis-associated acute kidney injury, lactylation-linked cytoskeletal signalling contributes to renal dysfunction. This article synthesizes the QuickGO definition with verified PubMed literature to explain what happens during positive regulation of Rho protein signal transduction, which genes and proteins are involved, how the process is regulated, and which CRISPR and multi-omics methods are best suited to study it.
positive regulation of Rho protein signal transduction At A Glance
| GO ID | GO:0035025 |
|---|---|
| GO term | positive regulation of Rho protein signal transduction |
| Ontology | biological_process |
| Synonym | activation of Rho protein signal transduction; stimulation of Rho protein signal transduction; up regulation of Rho protein signal transduction; up-regulation of Rho protein signal transduction; upregulation of Rho protein signal transduction |
| Major function | Increases the frequency, rate or extent of Rho protein signal transduction, promoting cytoskeletal remodelling, cell polarity and migration |
| Upstream inputs | GEFs, adhesion receptors, growth factor receptors, WNT-FZD complexes and mechanical cues |
| Downstream outputs | ROCK, formins, WAVE and Hippo/YAP-linked transcriptional programs |
| Disease relevance | Cancer invasion, immune suppression, sepsis-associated kidney injury and hepatocarcinogenesis |
| Research methods | CRISPR KO/point-mutation/knock-in, live imaging, GTPase pull-downs, transcriptomics and proteomics |
What Is GO:0035025?
In plain terms, GO:0035025 is the set of biological events that turn up the volume on Rho protein signal transduction. The QuickGO definition states: any process that activates or increases the frequency, rate or extent of Rho protein signal transduction. This means the term does not describe Rho signalling itself, but the positive control layer that makes Rho GTPase signalling more frequent, faster or more extensive. Such positive regulation typically involves recruiting or activating guanine nucleotide exchange factors (GEFs), stabilizing GTP-bound Rho GTPases at membranes, or relieving negative regulators such as GAPs and GDIs. The outcome is increased downstream effector engagement, including ROCK, formins and WAVE complexes, which remodel the actin cytoskeleton and establish cell polarity.
Why Is positive regulation of Rho protein signal transduction Important in Cell Biology?
Positive regulation of Rho protein signal transduction is important because it converts transient biochemical signals into sustained changes in cell shape, adhesion and gene expression. Rho GTPases are not simply on/off switches; their positive regulators determine where and when active GTPase accumulates, thereby patterning the cell cortex and directing migration. This spatial control is essential for normal development, including mesothelium formation and lung growth, where ECM organization, ROCK signalling and cell polarity are coupled. When positive regulation is hijacked, the same machinery supports pathological outcomes such as melanoma amoeboid invasion, hepatocellular carcinoma progression and immune evasion. Consequently, understanding GO:0035025 is central to both basic cell biology and translational research.
• Controls actin cytoskeletal dynamics and cell polarity, which are fundamental to morphogenesis and tissue architecture.
• Drives directed cell migration and invasion, including amoeboid invasion in melanoma.
• Supports tumour-initiating abilities and cancer stem-like phenotypes.
• Modulates immune cell recruitment and Treg-mediated immunosuppression through Rho-GTPase/NF-kB signalling.
• Contributes to sepsis-associated acute kidney injury via cytoskeletal and lactylation-linked mechanisms.
• Interfaces with the Hippo/YAP axis to influence hepatocarcinogenesis.
• Regulates viral entry processes such as HBV NTCP translocation and macropinocytosis.
• Provides druggable nodes (GEFs, ROCK, downstream effectors) for therapeutic intervention.
• Serves as a rich source of CRISPR targets for functional genomics and library screening.
• Links mechanical and biochemical cues to transcriptional outputs, making it a systems-level integration hub.
What Happens During positive regulation of Rho protein signal transduction?
Upstream signal reception and GEF recruitment
In simple terms: First, a signal from outside or from adhesion tells the cell to activate Rho proteins.
Positive regulation begins when extracellular ligands, adhesion receptors or mechanical cues engage surface complexes. WNT11-FZD7-DAAM1 signalling exemplifies how a receptor complex can support tumour-initiating abilities and amoeboid invasion by feeding into Rho GTPase activation. Similarly, ECM organization and cell polarity during mesothelium formation require coordinated input into ROCK signalling. These inputs recruit guanine nucleotide exchange factors (GEFs) that promote the exchange of GDP for GTP on Rho GTPases, shifting them to the active state.
Membrane targeting and GTP loading
In simple terms: The activated Rho proteins are anchored at the membrane where they can do their job.
Once GEFs are engaged, Rho GTPases are targeted to specific membrane domains where GTP loading occurs. This spatial confinement is critical because it patterns the cell cortex and determines the direction of force generation. Positive regulation thus increases the frequency and extent of GTP loading, amplifying downstream signalling. In HBV entry, CDC42 supports NTCP translocation to the plasma membrane and macropinocytosis, illustrating how GTPase activation at the membrane can control cargo internalization.
Effector engagement and cytoskeletal remodelling
In simple terms: Active Rho proteins switch on effector proteins that reshape the cytoskeleton.
GTP-bound Rho GTPases bind effectors such as ROCK, formins and WAVE complexes, which nucleate actin filaments, promote actomyosin contractility and drive membrane protrusion. In mesothelium formation, ROCK signalling and cell polarity cooperate with ECM organization to shape the developing lung. In hepatocellular carcinoma, SPON2 promotes M1-like macrophage recruitment and inhibits metastasis through distinct integrin-Rho GTPase-Hippo pathways, showing how effector engagement can be context-dependent.
Crosstalk with Hippo/YAP and transcriptional programs
In simple terms: Rho signalling also talks to gene-control pathways, changing what the cell expresses.
Positive regulation of Rho signalling is not confined to the cytoplasm; it feeds into transcriptional regulators. The oxytocin receptor regulates the Hippo/YAP axis to drive hepatocarcinogenesis, linking Rho-associated signalling to YAP-dependent gene expression. SPON2-mediated integrin-Rho GTPase-Hippo pathways further illustrate how Rho activation can be coupled to Hippo signalling to suppress or promote metastasis. This crosstalk converts short-term cytoskeletal changes into longer-term changes in cell state.
Immune and inflammatory modulation
In simple terms: Rho activation also changes how immune cells behave and communicate.
Positive regulation of Rho protein signal transduction shapes immune cell function. Blocking CXCR4+ CD4+ T cells reprograms Treg-mediated immunosuppression via the Rho-GTPase/NF-kB signalling axis, demonstrating that Rho activation status can influence immune tolerance. In sepsis-associated acute kidney injury, histone H3K18 and Ezrin lactylation promote renal dysfunction, implicating cytoskeletal and metabolic crosstalk in inflammatory organ injury. These examples show that GO:0035025 is relevant beyond classical cell migration.
Key Genes Involved in GO:0035025 positive regulation of Rho protein signal transduction
The following genes and proteins are experimentally implicated in positive regulation of Rho protein signal transduction or its downstream consequences, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RHOA | Core Rho GTPase switch controlling actomyosin contractility and polarity | Central node for CRISPR KO and point-mutation studies of GO:0035025 |
| RAC1 | Rho-family GTPase driving lamellipodia and migration | Frequently targeted in migration and invasion assays |
| CDC42 | Rho-family GTPase regulating filopodia, polarity and macropinocytosis | Supports HBV entry via NTCP translocation; useful for infection models |
| ROCK1 | Downstream effector kinase of RhoA | Key readout of positive regulation; targeted in mesothelium and cancer studies |
| ROCK2 | Downstream effector kinase of RhoA | Modulates contractility and immune signalling |
| WNT11 | Secreted ligand that activates non-canonical WNT signalling | Drives FZD7-DAAM1-dependent amoeboid invasion in melanoma |
| FZD7 | WNT receptor partnering with DAAM1 | Component of the WNT11-FZD7-DAAM1 module supporting tumour initiation |
| DAAM1 | Formin-like protein linking WNT signalling to Rho activation | Essential for WNT11-driven Rho-dependent invasion |
| SPON2 | Matricellular protein modulating integrin-Rho GTPase-Hippo pathways | Inhibits HCC metastasis via M1-like macrophage recruitment |
| OXTR | Oxytocin receptor regulating Hippo/YAP | Links hormonal signalling to Rho-associated hepatocarcinogenesis |
| CXCR4 | Chemokine receptor on CD4+ T cells | Modulates Treg immunosuppression via Rho-GTPase/NF-kB |
| EZR | Ezrin, an ERM protein connecting membrane to actin | Lactylation-linked renal dysfunction in sepsis |
| NTCP | Solute carrier mediating HBV entry | CDC42-dependent translocation to plasma membrane |
| YAP1 | Transcriptional co-activator downstream of Hippo | Readout of Rho-Hippo crosstalk in liver cancer |
| NFKB1 | Transcription factor downstream of Rho-GTPase signalling | Mediates immune reprogramming in Tregs |
| H3K18 | Histone mark associated with lactylation | Epigenetic link to renal dysfunction in sepsis |
| ITGB1 | Integrin beta-1 mediating ECM adhesion | Upstream of Rho GTPase-Hippo pathways in HCC |
How Is positive regulation of Rho protein signal transduction Regulated?
Positive regulation of Rho protein signal transduction is itself regulated at multiple levels. GEF activity, GAP activity and GDI binding collectively determine the steady-state level of active GTPase, and upstream receptors such as WNT11-FZD7-DAAM1 can locally concentrate activation. Mechanical and ECM-derived cues feed into ROCK-dependent contractility, which can further reinforce polarity and Rho activation in a feedback loop. In immune cells, chemokine receptor CXCR4 signalling modulates Rho-GTPase/NF-kB activity, showing that inflammatory inputs can tune this pathway. Metabolic and epigenetic signals also intersect: lactylation of histone H3K18 and Ezrin is associated with renal dysfunction in sepsis, suggesting that metabolic state can influence cytoskeletal signalling. Finally, viral entry pathways such as CDC42-dependent NTCP translocation demonstrate that pathogens can co-opt positive regulation for their own uptake.
positive regulation of Rho protein signal transduction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| WNT11 / FZD7 / DAAM1 | Melanoma amoeboid invasion and tumour initiation | CRISPR knockout melanoma cell lines plus invasion assays |
| SPON2 | Hepatocellular carcinoma metastasis and macrophage recruitment | Knockout and overexpression HCC models with co-culture |
| OXTR | Hepatocarcinogenesis via Hippo/YAP | Liver cancer cell lines with point-mutation and knock-in reporters |
| CXCR4 | Treg-mediated immunosuppression | Primary T-cell CRISPR KO and NF-kB reporter assays |
| CDC42 / NTCP | HBV entry and macropinocytosis | Hepatocyte cell lines with CDC42 KO and infection readouts |
Cancer invasion and metastasis
Enhanced positive regulation of Rho protein signal transduction supports tumour cell invasion and metastasis. WNT11-FZD7-DAAM1 signalling supports tumour-initiating abilities and amoeboid invasion in melanoma, a mode of migration that depends on Rho-ROCK contractility. In hepatocellular carcinoma, SPON2 promotes M1-like macrophage recruitment and inhibits metastasis through distinct integrin-Rho GTPase-Hippo pathways, indicating that the balance of Rho activation can be pro- or anti-metastatic depending on context. The oxytocin receptor regulates the Hippo/YAP axis to drive hepatocarcinogenesis, further linking Rho-associated signalling to liver cancer.
Immune regulation and inflammation
Rho GTPase signalling shapes immune cell behaviour. Blocking CXCR4+ CD4+ T cells reprograms Treg-mediated immunosuppression via the Rho-GTPase/NF-kB signalling axis, highlighting a role for positive regulation in immune tolerance. In sepsis-associated acute kidney injury, histone H3K18 and Ezrin lactylation promote renal dysfunction, connecting metabolic and cytoskeletal signalling to inflammatory organ injury. These findings suggest that modulating Rho activation could influence inflammatory outcomes.
Infection and viral entry
Pathogens can exploit positive regulation of Rho signalling for entry. CDC42 supports HBV entry by promoting NTCP translocation to the plasma membrane and macropinocytosis, demonstrating that Rho-family GTPase activation is required for efficient viral uptake. This creates potential therapeutic angles for blocking infection by targeting host GTPase-dependent entry pathways.
Developmental and tissue morphogenesis disorders
Because Rho signalling patterns the cell cortex and controls polarity, its positive regulation is essential for normal development. Interplay of ECM organization, ROCK signalling and cell polarity drives mesothelium formation and lung growth, and disruption of these processes could contribute to developmental defects. Understanding GO:0035025 in developmental contexts may inform regenerative and congenital disease research.
From positive regulation of Rho protein signal transduction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate GEF required for Rho activation? | CRISPR knockout of the GEF in a migratory cell line followed by GTPase pull-down |
| Does a specific phosphorylation site on a Rho regulator control activation? | Point-mutation knock-in of the phospho-dead or phospho-mimetic residue |
| How does a disease-associated variant affect Rho signalling? | Knock-in of the variant allele with live imaging of the cortex |
| Where and when is a Rho effector active? | Tagged knock-in of the effector with fluorescent tag and live imaging |
| Can overexpression of a Rho activator drive invasion? | Doxycycline-inducible overexpression in melanoma or HCC cells |
| Which genes modify Rho-dependent immune suppression? | CRISPR library screening in primary T cells or Treg co-cultures |
How to Study the positive regulation of Rho protein signal transduction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell biosensor imaging | Spatiotemporal GTPase activation | Cortex patterning and migration studies |
| GTPase pull-down | Amount of active GTP-bound Rho | Validation of CRISPR or point-mutation effects |
| ROCK activity assay | Downstream contractility signalling | Mesothelium and cancer models |
| RNA-seq | Transcriptional changes downstream of Rho | Hippo/YAP target gene analysis |
| Proteomics | Protein abundance and modifications | Lactylation and cytoskeletal crosstalk |
| CRISPR library screening | Genes required for Rho-dependent phenotypes | Immune suppression and invasion screens |
| Infection assay | Viral entry efficiency | CDC42-dependent HBV entry |
| Co-culture assays | Macrophage recruitment and Treg function | Tumour-immune interaction studies |
Live-cell imaging of Rho biosensors
Genetically encoded biosensors that report GTP-bound Rho GTPases allow real-time visualization of positive regulation at the cell cortex. This approach reveals where and when active GTPase accumulates and how it patterns the cortex during migration and morphogenesis. Combining biosensors with CRISPR knockout of candidate regulators provides causal tests of their role in GO:0035025.
GTPase pull-down and effector-binding assays
Biochemical pull-downs using Rho-binding domains measure the amount of active GTPase in lysates. These assays are useful for validating CRISPR or point-mutation effects on positive regulation and for quantifying pathway output after receptor stimulation. They can be paired with ROCK activity readouts to connect activation to downstream contractility.
Transcriptomics and proteomics
RNA-seq and proteomics capture the transcriptional and protein-level consequences of altered Rho signalling. For example, Rho-Hippo crosstalk can be assessed by measuring YAP target genes after perturbation. Proteomic analysis of lactylation or post-translational modifications can reveal metabolic crosstalk with cytoskeletal regulators.
CRISPR screening and functional genomics
Pooled CRISPR screens enable unbiased discovery of genes that positively regulate Rho signalling. Libraries targeting GEFs, GAPs and effectors can be screened for effects on migration, invasion or immune suppression readouts. Such screens are particularly powerful when combined with biosensor-based sorting or imaging-based phenotyping.
How CRISPR Can Be Used to Study GO:0035025 positive regulation of Rho protein signal transduction
Knockout
CRISPR knockout of Rho GTPases, GEFs or effectors is the most direct way to test necessity in positive regulation of Rho protein signal transduction. For example, knocking out CDC42 can block NTCP translocation and HBV entry, providing a clean loss-of-function readout. Knockout of ROCK isoforms can reveal their specific contributions to mesothelium formation and lung growth. In cancer models, knockout of WNT11, FZD7 or DAAM1 can suppress amoeboid invasion and tumour initiation.
Point Mutation
Point-mutation knock-in allows precise interrogation of regulatory residues. Phospho-dead or phospho-mimetic mutations in Rho regulators can test whether specific phosphorylation events control activation state. Disease-associated variants in Rho pathway genes can be introduced to assess their impact on GTP loading and downstream signalling. This approach is especially valuable when complete knockout is lethal or confounded by adaptation.
Knock-in
Tagged knock-in of Rho GTPases or effectors with fluorescent or affinity tags enables live imaging and biochemical isolation of endogenous complexes. This preserves native regulation while allowing visualization of where positive regulation occurs. Knock-in of biosensor modules can also provide physiological readouts of GTPase activity in specific cell types.
Overexpression
Overexpression of wild-type or constitutively active Rho GTPases, GEFs or downstream effectors can drive pathway activation and reveal sufficiency. For example, overexpression of WNT11-FZD7-DAAM1 components can promote invasive phenotypes in melanoma cells. Inducible overexpression systems allow temporal control, which is important because sustained Rho activation can be toxic or trigger feedback.
How EDITGENE Supports positive regulation of Rho protein signal transduction Research
Researchers studying positive regulation of Rho protein signal transduction-related genes often need to determine whether a candidate gene is causally involved in pathway activation, cytoskeletal remodelling or disease phenotypes. EDITGENE provides publication-ready CRISPR cell models and screening services that let you move from correlation to causation with validated knockout, point-mutation, knock-in and overexpression lines.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of Rho protein signal transduction research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| F11r Knockout MB49 Cell Line | EDJ-KQ54 | Mouse | 16456 | Details Get a Quote |
| F2RL1 Knockout HEK293T Cell Line | EDJ-KQ222 | Human | 2150 | Details Get a Quote |
| ARRB1 Knockout HEK293 Cell Line | EDJ-KQ608 | Human | 408 | Details Get a Quote |
| TEK Knockout HEK293 Cell Line | EDJ-KQ759 | Human | 7010 | Details Get a Quote |
| F2R Knockout HEK293 Cell Line | EDJ-KQ793 | Human | 2149 | Details Get a Quote |
| LPAR1 Knockout HEK293 Cell Line | EDJ-KQ832 | Human | 1902 | Details Get a Quote |
| SEMA4D Knockout HEK293 Cell Line | EDJ-KQ936 | Human | 10507 | Details Get a Quote |
| APOA1 Knockout HEK293 Cell Line | EDJ-KQ1462 | Human | 335 | Details Get a Quote |
| PLXNB1 Knockout HEK293 Cell Line | EDJ-KQ1466 | Human | 5364 | Details Get a Quote |
| MCF2L Knockout HEK293 Cell Line | EDJ-KQ2138 | Human | 23263 | Details Get a Quote |
| FXR1 Knockout HEK293 Cell Line | EDJ-KQ2559 | Human | 8087 | Details Get a Quote |
| ADGRG1 Knockout HEK293 Cell Line | EDJ-KQ2788 | Human | 9289 | Details Get a Quote |
| ROBO1 Knockout HEK293 Cell Line | EDJ-KQ2946 | Human | 6091 | Details Get a Quote |
| COL3A1 Knockout HEK293 Cell Line | EDJ-KQ3118 | Human | 1281 | Details Get a Quote |
| GPR4 Knockout HEK293 Cell Line | EDJ-KQ4761 | Human | 2828 | Details Get a Quote |
Displaying Records 1 To 15 Of 122 Records
- 1
- 2
- Next Page »
Frequently Asked Questions About positive regulation of Rho protein signal transduction
What is GO:0035025 positive regulation of Rho protein signal transduction?
GO:0035025 is a Gene Ontology biological_process term defined as any process that activates or increases the frequency, rate or extent of Rho protein signal transduction.
What genes are involved in positive regulation of Rho protein signal transduction?
Key genes include RHOA, RAC1, CDC42, ROCK1, ROCK2, WNT11, FZD7, DAAM1, SPON2, OXTR, CXCR4, EZR and NTCP, based on published studies.
How is Rho protein signal transduction activated?
It is activated when GEFs promote GTP loading on Rho GTPases at specific membrane domains, often downstream of receptors, adhesion complexes or mechanical cues.
Why is positive regulation of Rho signalling important in cancer?
It supports tumour-initiating abilities, amoeboid invasion and metastasis, and can interact with Hippo/YAP pathways in liver cancer.
What role does CDC42 play in this process?
CDC42 is a Rho-family GTPase that supports HBV entry by promoting NTCP translocation to the plasma membrane and macropinocytosis.
How can I study positive regulation of Rho protein signal transduction in the lab?
Common methods include live-cell biosensor imaging, GTPase pull-downs, ROCK activity assays, RNA-seq, proteomics and CRISPR screens.
What CRISPR models are available for Rho signalling research?
Knockout, point-mutation, tagged knock-in and overexpression models can be generated for Rho GTPases, GEFs and effectors to test necessity and sufficiency.
Does Rho signalling affect the immune system?
Yes, Rho-GTPase/NF-kB signalling modulates Treg-mediated immunosuppression, and Rho-dependent macrophage recruitment has been observed in hepatocellular carcinoma.
Is positive regulation of Rho signalling involved in kidney disease?
Histone H3K18 and Ezrin lactylation promote renal dysfunction in sepsis-associated acute kidney injury, linking cytoskeletal signalling to kidney injury.
What is the difference between Rho signalling and its positive regulation?
Rho signalling is the core GTPase switch, while positive regulation (GO:0035025) specifically describes processes that increase the frequency, rate or extent of that signalling.
Conclusion
GO:0035025 positive regulation of Rho protein signal transduction is a central biological_process that amplifies Rho GTPase signalling to control cytoskeletal dynamics, cell polarity, migration and gene expression. Its dysregulation contributes to cancer invasion, immune suppression, infection and organ injury, making it a high-value target for mechanistic and translational research. By combining CRISPR knockout, point-mutation, knock-in and overexpression models with live imaging, multi-omics and library screening, researchers can dissect this pathway with precision. EDITGENE offers the full suite of services needed to build publication-ready models and accelerate discovery in this field.
References
- 1. Qiao J et al.. 2024. Histone H3K18 and Ezrin Lactylation Promote Renal Dysfunction in Sepsis-Associated Acute Kidney Injury.. Adv Sci (Weinh) 11(28):e2307216 PMID: 38767134
- 2. Bement WM et al.. 2024. Patterning of the cell cortex by Rho GTPases.. Nat Rev Mol Cell Biol 25(4):290-308 PMID: 38172611
- 3. Zhang YL et al.. 2018. SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways.. Cancer Res 78(9):2305-2317 PMID: 29440144
- 4. Yang H et al.. 2025. Oxytocin Receptor Regulates the Hippo/YAP Axis to Drive Hepatocarcinogenesis.. Cancer Res 85(19):3752-3770 PMID: 40742309
- 5. Rodriguez-Hernandez I et al.. 2020. WNT11-FZD7-DAAM1 signalling supports tumour initiating abilities and melanoma amoeboid invasion.. Nat Commun 11(1):5315 PMID: 33082334
- 6. Liu X et al.. 2025. Interplay of ECM organization, ROCK signaling, and cell polarity drives mesothelium formation and lung growth.. Nat Commun 16(1):9610 PMID: 41168230
- 7. Cao C et al.. 2025. Blocking CXCR4(+) CD4(+) T cells reprograms T(reg)-mediated immunosuppression via modulating the Rho-GTPase/NF-κB signaling axis.. Genome Med 17(1):85 PMID: 40760450
- 8. Cui S et al.. 2025. CDC42 supports HBV entry by NTCP translocation to the plasma membrane and macropinocytosis.. EMBO Rep 26(21):5239-5269 PMID: 40954218
